Circulating microRNAs (cimiRNAs) are a class of non-encoding RNAs found in bodily fluids
such as blood, cerebrospinal fluid (CSF) and tears. CimiRNAs have been implicated as …

Oral cancer is one of the leading cancers in South-Asian countries. Despite the easy access
of the oral cavity, the detection and five year survival rates of OSCC patients are dismal …

Simple Summary Lung cancer is the leading cause of cancer death worldwide. Detecting
lung malignancies promptly is essential for any anticancer treatment to reduce mortality and …

MicroRNAs (miRNAs) are promising molecules that can regulate gene expression, and their
expression level and type have been associated with early diagnosis, targeted therapy, and …

Liquid biopsy-based biomarkers, such as microRNAs, represent valuable tools for patient
management, but often do not make it to integration in the clinic. We aim to explore issues …

Introduction Breast cancer (BC) is the most frequent malignant disease in women worldwide
and is therefore challenging for the healthcare system. Early BC detection remains a leading …

We have identified and validated a spaceflight-associated microRNA (miRNA) signature that
is shared by rodents and humans in response to simulated, short-duration and long-duration …

With revolutionary advances in next-generation sequencing, the human transcriptome has
been comprehensively interrogated. These discoveries have highlighted the emerging …

Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease.
Definitive diagnosis of the progressive form, non-alcoholic steatohepatitis (NASH), requires …

Breast cancer is one of the genetic diseases causing a high mortality among women around
the world. Despite the availability of advanced diagnostic tools and treatment strategies, the …